XML 58 R36.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Investments (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2024
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Investments | Equity investments by measurement category as of June 30, 2024 and June 30, 2023 were as follows (in thousands):
Measurement category | 2024 |  | 2023
Fair value | $ | 12,026 |  |  | $ | 12,423 |
Measurement alternative | 73,739 |  |  | 68,748 |
Equity method | 65,462 |  |  | 65,366 |
Total | $ | 151,227 |  |  | $ | 146,537 |
Schedule of Changes in Equity Investments | The following table shows a reconciliation of the changes in our equity investments for the year ended June 30, 2024 (in thousands):
| Non-marketable securities |  | Marketable securities |  | Equity method investments |  | Total
Balance at the beginning of the period | $ | 68,748 |  |  | $ | 12,423 |  |  | $ | 65,366 |  |  | $ | 146,537 |
Additions to investments | 8,640 |  |  | 1,000 |  |  | 3,125 |  |  | 12,765 |
Observable price adjustments on non-marketable equity securities | 2,315 |  |  | — |  |  | — |  |  | 2,315 |
Impairment of investments | (4,963) |  |  | — |  |  | — |  |  | (4,963) |
Proceeds from exits of investments | (1,000) |  |  | — |  |  | — |  |  | (1,000) |
Unrealized losses on marketable equity securities | — |  |  | (1,397) |  |  | — |  |  | (1,397) |
Loss attributable to equity method investments | — |  |  | — |  |  | (1,848) |  |  | (1,848) |
Foreign currency translation adjustments | (1) |  |  | — |  |  | (1,181) |  |  | (1,182) |
Carrying value at the end of the period | $ | 73,739 |  |  | $ | 12,026 |  |  | $ | 65,462 |  |  | $ | 151,227 |
The following table shows a reconciliation of the changes in our equity investments for the year ended June 30, 2023 (in thousands):
| Non-marketable securities |  | Marketable securities |  | Equity method investments |  | Total
Balance at the beginning of the period | $ | 39,290 |  |  | $ | 9,167 |  |  | $ | 9,918 |  |  | $ | 58,375 |
Additions to investments (1) | 21,738 |  |  | 4,991 |  |  | 62,733 |  |  | 89,462 |
Observable price adjustments on non-marketable equity securities | 12,612 |  |  | — |  |  | — |  |  | 12,612 |
Impairment of investments | (4,892) |  |  | — |  |  | — |  |  | (4,892) |
Realized gains on marketable and non-marketable equity securities | 3,937 |  |  | — |  |  | — |  |  | 3,937 |
Proceeds from exits of investments | (3,937) |  |  | — |  |  | — |  |  | (3,937) |
Unrealized losses on marketable equity securities | — |  |  | (1,735) |  |  | — |  |  | (1,735) |
Loss attributable to equity method investments | — |  |  | — |  |  | (7,265) |  |  | (7,265) |
Dividends received | — |  |  | — |  |  | (2,873) |  |  | (2,873) |
Foreign currency translation adjustments | — |  |  | — |  |  | 2,853 |  |  | 2,853 |
Carrying value at the end of the period | $ | 68,748 |  |  | $ | 12,423 |  |  | $ | 65,366 |  |  | $ | 146,537 |
(1)Includes additions from purchases and an equity method investment acquired and measured at fair value via our acquisition of MEDIFOX DAN. Refer to Note 17 herein.

X
- Definition Schedule Of Changes In Equity Investments [Table Text Block] + References No definition available. + Details
Name: | rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock
Namespace Prefix: | rmd_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Investments [Table Text Block] + References No definition available. + Details
Name: | rmd_ScheduleOfInvestmentsTableTextBlock
Namespace Prefix: | rmd_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration